SVEIN SALVESEN AS
Operating
Utføre helsetjenester, produksjon og salg,
forskning, informasjon og konsulentvirksomhet, investering og utleie,
samt deltagelse i annen virksomhet.
Øyelegetjenester og behandling.
Keywords
medical practicesspecialists
Organization
- CEO
- SO
- Chairman of the board
- SO
- Years since formation
- 15 years
- since Oct 8, 2011
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 6
Ownership
- Number of shares and share classes
- 100
- 2 share classes
- Total number of shareholders
- 5
- persons
Financials
- Total operating income 2025
- 14,384,913
- NOK
- Annual total result 2025
- 8,346,098
- NOK
- Total equity 2025
- 48,844,955
- NOK
Last update: Sep 21, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
SO | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
SO | Chairman | - |
JH | Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
OS | - | 70 % directly |
SA 1987 | - | 10 % directly |
SY | - | 10 % directly |
KH | - | 10 % directly |
Last update: Feb 22, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
OS | Class B shares | 45 | 45 % |
OS | A-shares | 25 | 25 % |
SA 1987 | Class B shares | 10 | 10 % |
SY | Class B shares | 10 | 10 % |
KH | Class B shares | 10 | 10 % |
Shares owned by the SVEIN SALVESEN AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 60 | 50 % | |
| Class B shares | 44,257 | 1.82 % | |
| Ordinary shares | 2,000 | 1.75 % | |
| Ordinary shares | 2,000 | 1.72 % | |
G Under liquidation | Ordinary shares | 15,000 | 1 % |
| Ordinary shares | 3,000 | 0.9 % | |
| Ordinary shares | 25,800 | 0.4 % | |
| Ordinary shares | 2,819 | 0.27 % | |
| Ordinary shares | 1,258 | 0.2 % | |
| Ordinary shares | 861 | 0.13 % | |
| Ordinary shares | 7,257,812 | 0.13 % | |
| Ordinary shares | 2,118 | 0.12 % | |
| Ordinary shares | 1,423 | 0.09 % | |
| Ordinary shares | 355 | 0.05 % | |
| Ordinary shares | 1,820 | 0.04 % | |
| Ordinary shares | 2,151 | 0.04 % | |
| Ordinary shares | 351 | 0.02 % | |
| Ordinary shares | 1,191 | 0.02 % | |
S Closed | NO0006001502 | 4,292 | < 0.01 % |
| Ordinary shares | 9,584 | < 0.01 % | |
| Ordinary shares | 2,225 | < 0.01 % | |
| Ordinary shares | 10,486 | < 0.01 % | |
| Ordinary shares | 4,464 | < 0.01 % | |
P | Ordinary shares | 125,652 | < 0.01 % |
| Ordinary shares | 6,321 | < 0.01 % | |
| Ordinary shares | 7,812 | < 0.01 % | |
| Ordinary shares | 1,613 | < 0.01 % | |
| Ordinary shares | 435 | < 0.01 % | |
| Ordinary shares | 6,837 | < 0.01 % | |
| Ordinary shares | 2,130 | < 0.01 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 14,384,913 | 12,359,406 | 12,039,907 | 12,340,880 | 10,217,489 |
Annual Total Result | 8,346,098 | 6,244,018 | 6,145,478 | 7,725,595 | 8,933,691 |
Total assets | 58,973,118 | 50,715,231 | 48,988,051 | 48,323,259 | 55,315,031 |
Total liabilities | 10,128,163 | 9,416,374 | 27,733,213 | 25,513,898 | 31,331,266 |
Total equity | 48,844,955 | 41,298,856 | 21,254,839 | 22,809,360 | 23,983,765 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 14,384,913 | 12,359,406 | 12,039,907 | 12,340,880 | 10,217,489 |
Total operating costs | 4,877,588 | 4,431,123 | 4,072,168 | 4,103,000 | 4,076,158 |
Operating result | 9,507,326 | 7,928,284 | 7,967,739 | 8,237,880 | 6,141,331 |
Financial income/costs | 921,104 | -86,345 | -180,518 | 1,748,805 | 4,195,053 |
Profit before tax | 10,428,429 | 7,841,939 | 7,787,221 | 9,986,685 | 10,336,384 |
Total tax & extraordinary income/cost | 2,082,331 | 1,597,921 | 1,641,743 | 2,261,090 | 1,402,693 |
Annual Total Result | 8,346,098 | 6,244,018 | 6,145,478 | 7,725,595 | 8,933,691 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 | 0 |
Total current assets | 58,973,118 | 50,715,231 | 48,988,051 | 48,323,259 | 55,315,031 |
Total assets | 58,973,118 | 50,715,231 | 48,988,051 | 48,323,259 | 55,315,031 |
Short term debt | 2,507,767 | 2,144,056 | 2,111,163 | 2,704,157 | 1,921,524 |
Long term debt | 7,620,396 | 7,272,319 | 25,622,050 | 22,809,742 | 29,409,742 |
Total liabilities | 10,128,163 | 9,416,374 | 27,733,213 | 25,513,898 | 31,331,266 |
Contributed capital | 34,250,000 | 35,050,000 | 15,050,000 | 15,050,000 | 15,050,000 |
Retained earnings | 14,594,955 | 6,248,856 | 6,204,839 | 7,759,360 | 8,933,765 |
Total equity | 48,844,955 | 41,298,856 | 21,254,839 | 22,809,360 | 23,983,765 |
Total equity and liabilities | 58,973,118 | 50,715,231 | 48,988,051 | 48,323,259 | 55,315,031 |
Classification
21st company classification
BETA
Small company
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
Q
Main industrial area
Human health and social work activities
86
Activity
Human health activities
86.2
Main industrial group
Medical and dental practice activities
86.22
Industrial group
Specialist medical practice activities
86.221
Industrial group
Physicians, specialists other than psychiatrists